SHEL Q1 2026 Earnings Strong EPS Beat Amid Market Headwinds LSF Q1 2026 Earnings Stunning EPS Beat Drives Positive Investor Sentiment Upstream Bio Inc UPB Q1 2026 Earnings Narrowed Loss Per Share as Clinical Pipeline Advances Immunome Q1 2026 Earnings EPS Beats Estimates Despite No Revenue Stock Declines GENB Q1 2026 Earnings PreRevenue Biotech Misses EPS Estimates Shares Rise on Operational Progress MGX Q1 2026 Earnings Missed Expectations as PreRevenue Biotech Advances Gene Editing Pipeline